[Acute and long-term treatment for bipolar depression].
Bipolar depression is linked with substantial burden and a high suicide risk, making a rapid and highly efficacious treatment mandatory. However, similar to mania, aspects of long-term treatment should already be considered at treatment initiation. With comparable efficacy, drugs with a beneficial safety and tolerability profile should be preferred. Additional psychotherapy can also noticeably improve both short- and long-term outcome of bipolar depression. Electroconvulsive therapy (ECT) still has its place in severe, treatment-resistant bipolar depression. Whereas ECT is a domain of specialised centres, correct diagnosis and both pharmacological and psychotherapeutic treatment initiation are essential tasks of primary care practitioners and secondary care psychiatrists.
Grunze
H
H
Institute of Neuroscience, Psychiatry, Newcastle University, RVI, Queen Victoria Road, Newcastle upon Tyne NE1 4LP, UK. Heinz.Grunze@ncl.ac.uk
Dargel
S
S
D000208:Acute Disease; D000928:Antidepressive Agents / Q000627:therapeutic use*; D001714:Bipolar Disorder / Q000175:diagnosis* / Q000523:psychology / Q000628:therapy*; D002908:Chronic Disease; D004565:Electroconvulsive Therapy / Q000639:trends*; D006801:Humans; D011613:Psychotherapy / Q000639:trends*
D000928:Antidepressive Agents
Arch Gen Psychiatry. 2000 May;57(5):481-9
10807488
Mol Psychiatry. 2005 May;10(5):456-69
15724143
J Clin Psychiatry. 2003 Feb;64(2):144-51
12633122
J Clin Psychiatry. 2009 Feb;70(2):223-31
19200421
J Clin Psychopharmacol. 1998 Feb;18(1):38-49
9472841
Arch Gen Psychiatry. 2003 Apr;60(4):402-7
12695318
Am J Psychiatry. 1972 Jul;129(1):44-7
4556087
Br J Psychiatry. 2009 Jan;194(1):4-9
19118318
J Clin Psychiatry. 2009 Sep;70(9):1273-80
19689918
BMJ. 2009 Aug 11;339:b2880
19671933
Biol Psychiatry. 2003 Apr 15;53(8):691-700
12706955
N Engl J Med. 2007 Apr 26;356(17):1711-22
17392295
Int Clin Psychopharmacol. 1989 Oct;4(4):313-22
2607128
Arch Gen Psychiatry. 2003 Nov;60(11):1079-88
14609883
Bipolar Disord. 2009 Aug;11(5):453-73
19624385
J Clin Psychopharmacol. 1993 Dec;13(6):397-408
8120153
J Affect Disord. 2010 Apr;122(1-2):1-9
19926140
J Clin Psychiatry. 2008 Oct;69(10):1589-601
19192442
World J Biol Psychiatry. 2010 Mar;11(2):81-109
20148751
Neuropsychopharmacology. 2003 Jul;28(7):1374-82
12784116
J Clin Psychiatry. 1997 Nov;58(11):470-8
9413412
J Affect Disord. 2001 Dec;67(1-3):141-6
11869761
Acta Psychiatr Scand. 2008 Nov;118(5):347-56
18727689
Clin Pharmacokinet. 1996 Sep;31(3):198-214
8877250
J Psychiatr Res. 2007 Apr-Jun;41(3-4):360-9
16081106
Am J Psychiatry. 2006 Feb;163(2):210-6
16449473
Br J Psychiatry. 2009 Mar;194(3):260-5
19252157
Am J Psychiatry. 2007 Aug;164(8):1242-9
17671288
J Clin Psychiatry. 2006 Jan;67(1):48-55
16426088
J ECT. 2007 Jun;23(2):120-3
17548985
Bipolar Disord. 2008 Mar;10(2):231-7
18271901
J Affect Disord. 2002 Apr;68(2-3):167-81
12063145
Am J Psychiatry. 2003 Jul;160(7):1252-62
12832239
J Affect Disord. 2009 Nov;118(1-3):55-9
19223079
Int J Neuropsychopharmacol. 2007 Dec;10 Suppl 1:S1-207
18096106
Biol Psychiatry. 2009 Aug 1;66(3):298-301
19358978
Am J Psychiatry. 2004 Feb;161(2):217-22
14754766
Lancet. 2009 Aug 22;374(9690):620-7
19595447
J Clin Psychiatry. 2004 Mar;65(3):432-41
15096085